APA (7th ed.) Citation

A, S., A, B., S, K., & C, N. (2024). Implications of Protein and Sarcopenia in the Prognosis, Treatment, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Nutrients, 16(5), . https://doi.org/10.3390/nu16050658

Chicago Style (17th ed.) Citation

A, Singh, Buckholz A, Kumar S, and Newberry C. "Implications of Protein and Sarcopenia in the Prognosis, Treatment, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)." Nutrients 16, no. 5 (2024). https://doi.org/10.3390/nu16050658.

MLA (9th ed.) Citation

A, Singh, et al. "Implications of Protein and Sarcopenia in the Prognosis, Treatment, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)." Nutrients, vol. 16, no. 5, 2024, https://doi.org/10.3390/nu16050658.